6547 高端疫苗 / 融資融券(年)
融資融券統計
| 11/13 資券狀況 | 2026年統計資料 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
率 | 互抵 | 當沖 | 餘額 | 張數 | 率 | 張數 | 張數 | ||||||||
| 1 | 2增→2減 | 6,105 | +6,311 | +103% | 13,294 (08/26) | 5,838 (01/27) | |||||||||
| 75 | +27 | +36% | 4,378 (08/27) | 0 (04/24) | |||||||||||
資券累計增減統計
11/12 ~11/13 | 11/11 ~11/13 | 11/09 ~11/13 | 11/02 ~11/13 | 10/15 ~11/13 | 08/17 ~11/13 | 05/18 ~11/13 | '25/11/14 ~11/13 | '23/11/15 ~11/13 | ||
|---|---|---|---|---|---|---|---|---|---|---|
(增減幅) | -42 (-0.34%) | +133 (+1.08%) | +72 (+0.58%) | -128 (-1.02%) | -335 (-2.63%) | +758 (+6.5%) | +3,265 (+35.68%) | +6,738 (+118.67%) | +5,911 (+90.87%) | - |
(增減幅) | -359 (-77.87%) | -23 (-18.4%) | -18 (-15%) | -277 (-73.09%) | -582 (-85.09%) | -2,376 (-95.88%) | -669 (-86.77%) | +14 (+15.91%) | -300 (-74.63%) | - |
(增減幅) | +163 (+2.83%) | +230 (+4.04%) | +387 (+7%) | +807 (+15.79%) | +501 (+9.25%) | -8,188 (-58.04%) | -5,114 (-46.35%) | -5,314 (-47.31%) | +13 (+0.22%) | - |
| -2.88 | -0.2 | -0.15 | -2.2 | -4.54 | -20.43 | -7.6 | -0.73 | -5.36 | - |
(%) | (千張) | 互抵 (千張) | 當沖 (%) | 比 (%) | 當沖 (%) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
率% | 率% | |||||||||||||||||||
| 2026 | 674 | 43.3 | 35.7 | 1.32 | +6.3 | 12.4 | 14.2 | 6.53 | 14.8 | 8.17 | +0.05 | 0.1 | 0.11 | 4.75 | 0.71 | 0.82 | 37 | |||
| 2025 | 526 | 31.7 | 28.2 | 0.84 | +2.7 | 6.1 | 7.42 | 5.73 | 5.92 | 0.29 | -0.11 | 0.08 | 0.09 | 4.86 | 0.92 | 1.23 | 39 | |||
| 2024 | 282 | 14.9 | 15.9 | 2.11 | -3.11 | 3.53 | 4.29 | 2.35 | 2.2 | 0.01 | -0.16 | 0.18 | 0.22 | 0.12 | 0.04 | 5.24 | 24.4 | |||
| 2023 | 660 | 33.3 | 30.6 | 0.64 | +2.01 | 6.64 | 8.08 | 10.3 | 10.8 | 1.48 | -0.98 | 0.35 | 0.42 | 0.47 | 0.07 | 5.26 | 38.8 | |||
| 2022 | 819 | 29.7 | 24.1 | 0.93 | +4.63 | 4.63 | 5.64 | 8.32 | 10.3 | 0.67 | +1.33 | 1.33 | 1.61 | 0.57 | 0.07 | 28.6 | 47.9 | |||
| 2021 | 924 | |||||||||||||||||||
| 2020 | 1,114 | |||||||||||||||||||
| 2019 | 38.4 | |||||||||||||||||||
| 2018 | 88.8 | |||||||||||||||||||

